Epigenetic Mechanisms Involved in Cisplatin-Induced Nephrotoxicity: An Update
Cisplatin is an antineoplastic drug used for the treatment of many solid tumors. Among its various side effects, nephrotoxicity is the most detrimental. In recent years, epigenetic regulation has emerged as a modulatory mechanism of cisplatin-induced nephrotoxicity, involving non-coding RNAs, DNA me...
Saved in:
Main Authors: | Pía Loren (Author), Nicolás Saavedra (Author), Kathleen Saavedra (Author), Tomás Zambrano (Author), Patricia Moriel (Author), Luis A. Salazar (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
by: Pía Loren, et al.
Published: (2022) -
miR-6805-5p as a biomarker of cisplatin-induced nephrotoxicity in patients with head and neck cancer
by: Nadine De Godoy Torso, et al.
Published: (2023) -
Antioxidants and cisplatin nephrotoxicity; an updated review on current knowledge
by: Ramin Tolouian, et al.
Published: (2023) -
Dibenzazepine Attenuates Against Cisplatin-Induced Nephrotoxicity in Rats: Involvement of NOTCH Pathway
by: Rana H. Abd El-Rhman, et al.
Published: (2020) -
Glutamine protects against cisplatin-induced nephrotoxicity by decreasing cisplatin accumulation
by: Hyun-Jung Kim, et al.
Published: (2015)